Cargando…
Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders
This scientific commentary refers to ‘Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau’ by Tsai et al. (doi:10.1093/brain/awab332).
Autores principales: | Rodriguez-Vieitez, Elena, Ashton, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677507/ https://www.ncbi.nlm.nih.gov/pubmed/34672320 http://dx.doi.org/10.1093/brain/awab399 |
Ejemplares similares
-
Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury
por: Derive, Marc, et al.
Publicado: (2011) -
The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?
por: Ferri, Evelyn, et al.
Publicado: (2021) -
Urine sTREM-1 may be a valuable biomarker in diagnosis and prognosis of sepsis-associated acute kidney injury
por: Su, Longxiang, et al.
Publicado: (2015) -
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2023) -
sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021)